Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 2003, p. 489-491, Vol. 41, No. 1
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.1.489-491.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Clinical Microbiology and Microbiology, Hacettepe University Medical School, Ankara 06100, Turkey,1 Division of Infectious Diseases, Department of Internal Medicine, Center for the Study of Emerging and Reemerging Pathogens, University of Texas Medical School, Houston, Texas 770302
Received 2 April 2002/ Returned for modification 15 July 2002/ Accepted 30 September 2002
|
|
|---|
|
|
|---|
-methyl-D-glucoside (MDG) (9; I. F. Salkin, W. R. Pruitt, A. A. Padhye, D. Sullivan, D. Coleman, and D. H. Pincus, Letter, J. Clin. Microbiol. 36:1467, 1998.). However, these characteristics are not definitive, and the similarity between the two species causes problems (7, 12, 14). A number of supplemental phenotypic approaches for the separation of the two species have recently been described; these include determining relative growth at 42 and 45°C (2, 10, 12, 15, 18), ß-glucosidase activity (12, 15), and colony color on CHROMagar (2, 12). In an effort to develop a routine approach to identifying this species, we studied the utility of identification based on selected phenotypic features (ability to grow at 42°C, ability to produce chlamydospores on cornmeal-Tween 80 agar, and sugar assimilation reactions as measured by the API 20 AUX system. We have confirmed the validity of this approach by PCR and restriction enzyme analysis of genomic DNA (REAG). During screening of >2,000 sequential bloodstream isolates collected from multiple centers in the United States as part of a multicenter study between 1995 and 1999, 772 isolates were tentatively identified as C. albicans at the referring center by different methods and were subsequently confirmed as C. albicans by the C. albicans CA50 kit (Murex Diagnostics, Inc., Norcross, Ga.) in our laboratory. In accordance with the National Committee for Clinical Laboratory Standards M27-A inoculum preparation procedure (6), isolates were prepared at a density of 1 x 103 to 5 x 103 cells/ml. For growth studies 100 µl of fungal inoculum was combined with 100 µl of double-strength RPMI 1640 in the wells of a 96-well round-bottom microdilution tray. Duplicate wells were used for each isolate, and identical trays for each target temperature were prepared. Growth was monitored visually after 24 and 48 h of incubation. Isolates with reduced growth relative to that of a known C. albicans isolate (approximately 50% less turbidity, similar to the MIC-2 end point used for antifungal susceptibility testing [6]) or no growth after 24 h at a temperature higher than 37°C were considered suspicious and were examined by determining assimilation profiles with the API 20C AUX system (bioMerieux Vitek, Inc., Hazelwood, Mo.) and chlamydospore production on cornmeal-Tween 80 agar.
PCR and REAG were used to confirm the identification of putative C. dubliniensis isolates. DNA was extracted by an adaptation of the methods of Scherer and Stevens (11). For restriction enzyme analysis of genomic DNA, DNA was digested with HinfI (Invitrogen, Carlsbad, Calif.) according to the manufacturer's instructions and then separated by electrophoresis. PCR was performed with the previously described C. dubliniensis-specific ACT-1-associated primer pairs DUBF and DUBR, which yield an amplimer of 288 bp (4).
C. dubliniensis type strain CD36 (courtesy of Derek Sullivan; lodged with the British National Collection of Pathogenic Fungi under accession no. NCPF 3949) and C. albicans ATCC 90028 (American Type Culture Collection) were used as positive and negative controls, respectively.
Of 772 candidate isolates, 149 showed reduced growth or no growth at 42°C (preliminary testing failed to identify any isolates that grew at 45°C). By API 20C AUX, 22 of the 149 isolates were identified as C. dubliniensis, 113 were identified as C. albicans, 13 were identified as Candida parapsilosis, and 1 was identified as Candida guilliermondii. Of the 113 C. albicans isolates, 11 showed no growth at 42°C but were capable of using both XYL and MDG. However, 9 of the 113 isolates identified as C. albicans failed to utilize XYL, and 1 of these 9 isolates also failed to assimilate MDG in the API 20C AUX system. There were thus 31 isolates with one or more sugar assimilation characteristics suggestive of C. dubliniensis (Table 1).
|
View this table: [in a new window] |
TABLE 1. Analysis of isolates with a sugar assimilation pattern potentially consistent with C. dubliniensisa
|
![]() View larger version (102K): [in a new window] |
FIG. 1. Amplification of ACT1-associated 288-bp fragment by PCR. Lane M, molecular weight marker (1-kb DNA ladder); lane 2, C. dubliniensis type strain CD36; lane 8, C. albicans reference strain ATCC 90028; lanes 1, 3 to 5, and 7, C. dubliniensis isolates (Table 1, isolates 10, 12, 11, 19, and 20, respectively); lane 6, C. albicans isolate (Table 1, isolate 22).
|
Our results show that the combination of an API 20C AUX identification as C. dubliniensis and the complete absence of growth at 42°C, particularly after 48 h of incubation, is strongly suggestive of C. dubliniensis. Production of chlamydospores by C. dubliniensis is very different from that by C. albicans (13, 14, 16). In our study, 19 of the 20 isolates which were confirmed as C. dubliniensis by PCR and REAG showed abundant chlamydospores on cornmeal-Tween 80 agar. We observed that the isolate that produced rare chlamydospores had smaller blastospores than other strains.
Placing the results in overall context, C. dubliniensis was identified in 20 of 758 (2.6%) bloodstream isolates that might normally have been identified as C. albicans. To understand the clinical significance and epidemiological role of C. dubliniensis, it is very important to identify it correctly in clinical specimens. It has been suggested that the most reliable tests currently used for discriminating C. albicans and C. dubliniensis are based on molecular techniques (1, 3, 4, 5, 8, 16, 17). As these techniques require molecular biology equipment that may not be available in many mycology laboratories, our data suggest that a temperature study can be used as a screening test. For isolates showing no growth after 48 h at 42°C, carbohydrate assimilation profiles with the API 20C AUX yeast identification system and chlamydospore production on cornmeal agar should be investigated. Isolates that fit the entire profile are highly likely to be C. dubliniensis rather than C. albicans.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»